Skip to main content
. 2015 Feb 10;6(9):6850–6861. doi: 10.18632/oncotarget.3190

Figure 3. Expression level of TACC3 corresponded with the progression of ESCC.

Figure 3

(A) A distinct distinction between TACC3 expression in ESCC tissues and non-tumor esophageal epithelial tissues was detected. (B) The expression of TACC3 increased progressively from Grade 1 to Grade 3 of ESCC. (C) Moreover, TACC3 expression in cases with lymphoid nodal metastasis was significantly higher than the expression in patients without lymphoid nodal metastasis. Data presented as means ± SD; N, normal esophageal tissues; IRS, the immunoreactivity score (*p < 0.05, **p < 0.01, ***p < 0.001).